Riemser leaves leveraged loans near empty
German pharmaceuticals firm Riemser allocated its €256m term loan dividend recapitalisation on Tuesday, according to one banker. The deal comes as deal flow in the levloan market dissipates.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: